| Vulcan Healthcare, Llc | |
|
7063 Veterans Pkwy # 200, Pell City, AL 35125-5114 | |
| (205) 777-9574 | |
| Not Available |
| Full Name | Vulcan Healthcare, Llc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot Surgery |
| Location | 7063 Veterans Pkwy # 200, Pell City, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336890250 | NPI | - | NPPES |
| 314 | Other | AL | AL STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | (* (Not Available)) | Primary |
| Provider Name | Geoffrey H Dye |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1609146273 PECOS PAC ID: 1153542238 Enrollment ID: I20141015001540 |
News Archive
Researchers have long known that sex hormones such as estrogen play a role in migraine. But there's been little research on how that works. Do women with migraine have higher estrogen levels in general? Higher levels at the peak of the monthly cycle?
Eating your greens may be even more important than previously thought, with the discovery that an immune cell population essential for intestinal health could be controlled by leafy greens in your diet.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.
Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha (evolocumab) Injection, the first proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor to be approved in Japan.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vulcan Healthcare, Llc #376, 732 Montgomery Highway, Vestavia, AL 35216 Ph: (205) 777-9574 | Vulcan Healthcare, Llc 7063 Veterans Pkwy # 200, Pell City, AL 35125-5114 Ph: (205) 777-9574 |
News Archive
Researchers have long known that sex hormones such as estrogen play a role in migraine. But there's been little research on how that works. Do women with migraine have higher estrogen levels in general? Higher levels at the peak of the monthly cycle?
Eating your greens may be even more important than previously thought, with the discovery that an immune cell population essential for intestinal health could be controlled by leafy greens in your diet.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.
Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha (evolocumab) Injection, the first proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor to be approved in Japan.
› Verified 3 days ago
Marvin Earl Williams Jr., DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4109 Cogswell Ave, Pell City, AL 35125 Phone: 205-814-1234 | |
Upperline Healthcare, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 4109 Cogswell Ave, Pell City, AL 35125 Phone: 205-814-1234 | |
Dr. Geoffrey Harrison Dye, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7063 Veterans Pkwy Ste 200, Pell City, AL 35125 Phone: 205-777-9574 Fax: 205-814-2334 |